Search results for "second"

showing 10 items of 3671 documents

EP11.09: Are femur and humerus lengths measured exactly by 3D ultrasound reliable parameters for the detection of Trisomy 21 in the second trimester?

2018

medicine.medical_specialtyRadiological and Ultrasound Technologymedicine.diagnostic_testbusiness.industryObstetrics and GynecologyGeneral Medicinemedicine.diseasemedicine.anatomical_structureReproductive MedicineSecond trimestermedicineRadiology Nuclear Medicine and imaging3D ultrasoundFemurHumerusRadiologyTrisomybusinessUltrasound in Obstetrics & Gynecology
researchProduct

EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study

2021

Abstract Aims To provide contemporary data on the implementation of European guideline recommendations for lipid-lowering therapies (LLTs) across different settings and populations and how this impacts low-density lipoprotein cholesterol (LDL-C) goal achievement. Methods and results An 18 country, cross-sectional, observational study of patients prescribed LLT for primary or secondary prevention in primary or secondary care across Europe. Between June 2017 and November 2018, data were collected at a single visit, including LLT in the preceding 12 months and most recent LDL-C. Primary outcome was the achievement of risk-based 2016 European Society of Cardiology (ESC)/European Atherosclerosis…

medicine.medical_specialtyRegistryStatinEpidemiologymedicine.drug_class030204 cardiovascular system & hematologyGuidelinesSecondary care03 medical and health sciences0302 clinical medicineEzetimibeRisk FactorsInternal medicinemedicineHumans030212 general & internal medicinePCSK9 InhibitorsDyslipidemiasSecondary preventionPrimary Health Carebusiness.industryAnticholesteremic AgentsStatinsCholesterol LDLGuidelineLipidsConfidence intervalCross-Sectional StudiesTreatment OutcomeCholesterolCardiovascular DiseasesObservational studyHydroxymethylglutaryl-CoA Reductase InhibitorsProprotein Convertase 9Cardiology and Cardiovascular MedicinebusinessBiomarkersmedicine.drugDA VINCI study
researchProduct

Gewicht und Funktion der Milz bei Polycythämie und Polyglobulie

1970

1. We have studied 50 patients with primary polycythemia by radioisotope scanning (“scintigraphy”). In 96% of these patients the weight of the spleen exceeded 300 g. The mean splenic weight was 720 g. 2. 93 % of 48 cases with secondary polycythemia revealed a mean splenic weight below 300 g, as detected by scintigraphy. The mean splenic weight in this group was 195 g. 3. The scintigraphic determination of splenic size allows polycythemia vera to be distiguished from secondary polycythemia with a high degree of accuracy

medicine.medical_specialtySecondary Polycythemiamedicine.diagnostic_testbusiness.industrySpleenScintigraphymedicine.diseaseGastroenterologymedicine.anatomical_structurePolycythemia verahemic and lymphatic diseasesInternal medicinemedicinePolycythemia rubra verabusiness
researchProduct

Dual-release hydrocortisone improves hepatic steatosis in patients with secondary adrenal insufficiency: A real-life study

2019

Background:Conventional glucocorticoid treatment has a significant impact on liver in patients with adrenal insufficiency. Dual-release hydrocortisone (DR-HC) provides physiological cortisol exposure, leading to an improvement in anthropometric and metabolic parameters. We aimed to evaluate the effects of 12-month DR-HC treatment on the hepatic steatosis index (HSI), a validated surrogate index of hepatic steatosis, in patients with secondary adrenal insufficiency (SAI).Methods:A total of 45 patients with hypopituitarism, 22 with hypogonadism, hypothyroidism, ACTH, and GH deficiencies, and 23 with hypogonadism, hypothyroidism, and ACTH deficiency, on replacement therapy for all the pituitar…

medicine.medical_specialtySecondary adrenal insufficiencyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismHypopituitarismHepatic steatosilcsh:Diseases of the endocrine glands. Clinical endocrinologyHypopituitarismSettore MED/13 - Endocrinologia03 medical and health sciences0302 clinical medicineInternal medicinemedicineAdrenal insufficiencyIn patientHydrocortisoneOriginal Researchlcsh:RC648-665business.industryhepatic steatosismedicine.diseaseInsulin sensitivityEndocrinology030220 oncology & carcinogenesisDual-release hydrocortisoneSteatosisLife studybusinessGlucocorticoidmedicine.drugSecondary adrenal insufficiency
researchProduct

Higher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the Albumin Italian Outcome Sepsis (ALBIOS) trial

2021

Abstract Background The role of intravenous immunoglobulins (IVIG) during sepsis is controversial, as different trials on IVIG have observed inconsistent survival benefits. We aimed to elucidate the possible association and clinical significance between circulating levels of immunoglobulins. Methods In a subset of 956 patients with severe sepsis and septic shock of the multicentre, open-label RCT ALBIOS, venous blood samples were serially collected 1, 2, and 7 days after enrolment (or at ICU discharge, whichever came first). IgA, IgG and IgM concentrations were assayed in all patients on day 1 and in a subgroup of 150 patients on days 2 and 7. Ig concentrations were measured employing a tur…

medicine.medical_specialtySepsiIgGSecondary infectionCritical Care and Intensive Care MedicineGastroenterologylaw.inventionSepsisRandomized controlled triallawInternal medicineSepsisSeptic shockRisk of mortalitymedicineClinical significanceMortalitybusiness.industrySeptic shockRC86-88.9ResearchMedical emergencies. Critical care. Intensive care. First aidVenous bloodmedicine.diseaseIgM ImmunoglobulinsbusinessIgA; IgG; IgM Immunoglobulins; Mortality; Sepsis; Septic shockIgM ImmunoglobulinIgACohort study
researchProduct

One year after the ESC/EAS guidelines on cholesterol control. What's the new evidence? What's missing?

2021

The recent ESC/EAS 2019 Guidelines for the management of dyslipidaemias are centred on the causal role of low density lipoprotein (LDL), or more generally apolipoprotein B (apoB)-containing lipoproteins, in atherosclerosis as an essential principle. Despite updated goals and recommendations, that have further highlighted the importance of a powerful reduction in LDL-C levels to reduce the individual CV risk, some challenges remain to be addressed in view of future guideline elaboration. In this review, we will summarize the new evidence from clinical trials since 2019 guideline release and discuss the possible challenges for the future.

medicine.medical_specialtySettore MED/09 - Medicina InternaApolipoprotein BControl (management)Guidelinechemistry.chemical_compoundRisk FactorsCardiovascular DiseasePrimary preventionCardiovascular disease DyslipidemiaInternal MedicineHumansMedicineIntensive care medicineDyslipidemiasSecondary preventionPrimary preventionbiologybusiness.industryCholesterolSecondary preventionLDL-C treatmentCholesterol LDLGuidelineAtherosclerosisClinical trialCholesterolchemistryCardiovascular Diseasesbiology.proteinlipids (amino acids peptides and proteins)Risk Factors: AtherosclerosiHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessEuropean Journal of Internal Medicine
researchProduct

Antiplatelets in stroke prevention

2014

Stroke is the second cause of death worldwide and one of the leading cause of disability. Due to the high rate of recurrence, in high risk-patients (eg patients affected by atherosclerotic vascular disease), long-term antiplatelet therapy reduces the risk of vascular events such as non-fatal myocardial infarction, non-fatal stroke, or vascular death. The percentage of reduction of the events can be estimated in approximately 25%. These data justify the directions that are given to us by the current guidelines for prevention of secondary stroke, which recommend the broad use of antiplatelet therapy both for the secondary prevention of stroke in patients with a history of non-cardioembolic st…

medicine.medical_specialtySettore MED/09 - Medicina InternaMEDLINEPrimary preventionSecondary PreventionmedicineAnimalsHumanscardiovascular diseasesMyocardial infarctionIntensive care medicineStrokeCause of deathPharmacologySecondary preventionAspirinAspirinbusiness.industrymedicine.diseasePrimary PreventionStrokeCardiovascular DiseasesPhysical therapyPlatelet aggregation inhibitorantiplatelets Stroke preventionCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation Inhibitorsmedicine.drug
researchProduct

Forms of Bullying and Associations Between School Perceptions and Being Bullied Among Finnish Secondary School Students Aged 13 and 15

2019

AbstractThe study aimed to examine the extent to which Finnish secondary school students experience bullying, how they are bullied, and whether being bullied is associated with school perceptions. The analyses were based on data from the Finnish part of the international Health Behaviour in School-aged Children (HBSC) study, and were obtained from 4262 students aged 13 and 15. The sample was nationally representative. Logistic regression analysis was performed to identify the associations between school perceptions and being bullied. Younger students reported being bullied more often than older students. Among younger students, boys were more often bullied than girls of the same age. There …

medicine.medical_specialtySocial Psychologyforms of bullyingyläkoululaisetmedia_common.quotation_subjecteducationLogistic regressionsukupuoliDevelopmental psychology03 medical and health sciences0302 clinical medicinekoulukiusaaminenPerceptionschool perceptionsDevelopmental and Educational Psychologymedicine0501 psychology and cognitive sciences030212 general & internal medicinesosioekonomiset tekijätmedia_commonSocial workbusiness.industryPublic health05 social sciencesSignificant differenceInternational healthLonelinessFeelingbullyingsecondary schoolkiusaaminenyläkoulumedicine.symptomPsychologybusinessvertaissuhteetSocial Sciences (miscellaneous)050104 developmental & child psychologyInternational Journal of Bullying Prevention
researchProduct

Mismatch negativity (MMN) elicited by changes in phoneme length: A cross-linguistic study

2006

Speech sounds representing different phonetic categories are typically easier to discriminate than sounds belonging to the same category. This phenomenon is referred to as the phoneme boundary effect. We aimed to determine whether, at neural level, this effect is indeed due to crossing the phoneme boundary. The mismatch negativity (MMN) brain response was measured for across- and within-category changes in Finnish phoneme length in native speakers and second-language users of Finnish as well as non-Finnish-speaking subjects. The results showed that the MMN amplitude was enhanced in the native speakers in comparison with the two non-native groups which, in turn, did not differ from each othe…

medicine.medical_specialtySpeech soundsMismatch negativityAudiology050105 experimental psychologyRussia03 medical and health sciences0302 clinical medicinemedicineHumansSpeech0501 psychology and cognitive sciencesMolecular BiologyFinlandLanguageCommunicationAnalysis of Variancebusiness.industryGeneral Neuroscience05 social sciencesBrainLinguisticsSecond languageDuration (music)Evoked Potentials AuditoryNeurology (clinical)businessPsychology030217 neurology & neurosurgeryDevelopmental BiologyCross linguistic
researchProduct

Follow-up after urinary diversion.

1999

With modern forms of urinary diversion being widely employed during recent years, the awareness of possible complications and appropriate follow-up strategies gains rising importance and current follow-up strategies are reviewed herewith. Follow-up investigations after urinary diversion have to address possible surgical complications, metabolic changes as well as the risk of secondary malignancies in the incorporated bowel segments. The most important and possible deleterious surgical complication is upper tract dilation and obstruction following ureteroenteric anastomotic stenosis and occurs in 2–30% depending on the surgical technique and evaluated series. The most appropriate follow-up s…

medicine.medical_specialtyTime Factorsbusiness.industryUrologyUrinary systemmedicine.medical_treatmentUrinary diversionFollow up studiesNeoplasms Second PrimaryUrinary DiversionSurgeryIntestinal malabsorptionUretermedicine.anatomical_structurePostoperative ComplicationsMalabsorption SyndromesMetabolic DiseasesMedicineHumansbusinessIntensive care medicinehuman activitiesFollow-Up StudiesUrologia internationalis
researchProduct